Johnson & Johnson
Dorota Herman is an experienced data scientist specializing in drug discovery, currently serving as a Principal Data Scientist at Johnson & Johnson Innovative Medicine since October 2023. Prior to this role, Dorota held various positions at The Janssen Pharmaceutical Companies of Johnson & Johnson from March 2017 to October 2023, including Senior Scientist in Discovery Data Science and Scientist in Computational Systems Biology. Dorota's earlier experience includes a postdoctoral researcher position at VIB and a PhD in Computational Biology from the University of Birmingham. Additional roles include research at MyCIB, a trainee position at the National Center for Biotechnology in Spain, and a traineeship at Université de Franche-Comté. Dorota's expertise encompasses omics data analysis, data integration, network analysis, data mining, and mathematical modeling of gene regulation, supported by an MSc Eng in Biomedical Engineering from Wrocław University of Science and Technology.
This person is not in any offices
Johnson & Johnson
541 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.